Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0HI3 stock hub

LON/0HI3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HI3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HI3

In the news

Latest news · LON/0HI3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-42.4

P25 -54.2P50 2.1P75 13.7

ROIC81.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HI3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	711
Employees Change	102%
Employees Change Percent	16.75
Enterprise value	$7.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US04280A1007
Last refreshed	2026-05-10
Market cap	$7.5B
Price	$73.55
Price currency	USD
Rev Per Employee	662,518.32x
Sector	Healthcare
Sic	2836
Symbol	lon/0HI3
Website	https://arrowheadpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.03%
EV Earnings	-31.6x
EV/FCF	-186.93x
EV/Sales	15.78x
FCF yield	-0.51%
P/B ratio	16.57x
P/S ratio	15.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-35.67%
EBITDA Margin	-31.6%
Gross margin	100%
Gross Profit	$471.1M
Gross Profit Growth	43,539.24%
Gross Profit Growth Q	10,461.32%
Gross Profit Growth3 Y	57.67%
Gross Profit Growth5 Y	68.7%
Net Income	$-227.9M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-40.56%
Profit Margin	-48.38%
Profit Per Employee	$-320,507
ROA	-7.22
Roa5y	-16.64
ROCE	-11.25
ROE	-42.37
Roe5y	-76.13
ROIC	81.47
Roic5y	-116.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	460.4%
Cagr3y	20.66%
Cagr5y	2.01%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	43,539.24x
Revenue Growth Q	10,461.32x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	57.67x
Revenue Growth5 Y	68.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$1.7B
Cash	$1.4B
Current Assets	$861.4M
Current Liabilities	$254.8M
Debt	$1B
Debt Equity	$2.29
Debt FCF	$-26.99
Equity	$453.6M
Interest Coverage	-2.4
Liabilities	$1.3B
Long Term Assets	$856.3M
Long Term Liabilities	$1B
Net Cash	$311.1M
Net Cash By Market Cap	$4.14
Net Debt Equity	$-0.69
Tangible Book Value	$460.4M
Tangible Book Value Per Share	$3.28
WACC	10.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.23
Net Working Capital	$-145.2M
Quick ratio	6.1
Working Capital	$1.2B
Working Capital Turnover	$0.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	459.74%
200-day SMA	49.55
3Y total return	75.7%
50-day SMA	64.99
50-day SMA vs 200-day SMA	50over200
5Y total return	10.44%
All Time High	92.16
All Time High Change	-20.19%
All Time High Date	2021-02-10
All Time Low	5.16
All Time Low Change	1,325.39%
All Time Low Date	2018-02-14
ATR	3.57
Beta	1.29
Ch YTD	10.92
High	77.95
High52	80.22
High52 Date	2026-05-07
High52ch	-8.31%
Low	72.96
Low52	12.58
Low52 Date	2025-05-08
Low52ch	484.75%
Ma50ch	13.17%
Price vs 200-day SMA	48.45%
RSI	55.4
RSI Monthly	74.17
RSI Weekly	69.67
Sharpe ratio	2.62x
Sortino ratio	4.69
Total Return	-10.94%
Tr YTD	10.92
Tr1m	22.77%
Tr1w	-1.54%
Tr3m	11.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-168M
Operating margin	-35.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	122,037,310%
Net Borrowing	-189,279,620.1
Shares Insiders	3.3%
Shares Institutions	73.48%
Shares Qo Q	2.05%
Shares Yo Y	10.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-90.2M
Average Volume	1,880.3x
Bv Per Share	3.31
CAPEX	$-11M
Ch1m	22.77
Ch1w	-1.54
Ch1y	459.7
Ch3m	11.85
Ch3y	75.7
Ch5y	10.44
Ch6m	90.77
Change	-5.05%
Change From Open	-4.48
Close	77.46
Days Gap	-0.59
Depreciation Amortization	18,398,731.7
Dollar Volume	155,631.8
Earnings Date	2026-08-05
EBIT	$-168M
EBITDA	$-148.8M
EPS	$-1.64
F Score	4
FCF	$-38.5M
FCF EV Yield	-0.53x
Financing CF	561,887,746
Fiscal Year End	September
Founded	2,003
Income Tax	$14.8M
Investing CF	-533,154,080
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Ma150	58.33
Ma150ch	26.09%
Ma20	72.07
Ma20ch	2.06%
Net CF	2,126,512
Next Earnings Date	2026-08-05
Open	77
Position In Range	11.82
Ppne	309,502,564.7
Price Date	2026-05-08
Ptbv Ratio	16.32
Relative Volume	1.2x
Revenue	471,050,526x
SBC By Revenue	10.96x
Share Based Comp	51,626,239
Tax By Revenue	3.15x
Tr6m	90.77%
Volume	2,116

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HI3 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HI3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HI3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+73.5%

Share of float held by funds and institutions

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.9%

Negative means the company is buying back shares.

Technical

LON/0HI3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.4

Neutral momentum band

Price vs 200-day MA

+48.4%

50/200-day relationship not available

Beta (5Y)

1.29

More volatile than the market

Sharpe ratio

2.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HI3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HI3 stock rating?

lon/0HI3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HI3 analysis?

The full report lives at /stocks/lon/0HI3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HI3?

The latest report frames lon/0HI3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HI3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.